Wataru Takeda
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Real-World Use of Maribavir for Refractory CMV Infection and Intolerance to Conventional Anti-CMV Agents After Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: May 07, 2026
Effectiveness of anti-CD19 CAR T-cell therapy for high-grade B-cell lymphoma in Japan: a single-institution analysis.
Journal: International journal of clinical oncology
Published: May 02, 2026
T-cell fitness, metabolic tumor volume, and serum LDH levels are associated with response to axicabtagene ciloleucel.
Journal: International journal of hematology
Published: January 19, 2026
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma.
Journal: International journal of clinical oncology
Published: January 09, 2026
Real-world effectiveness and safety of lisocabtagene maraleucel for relapsed/refractory large B cell lymphoma in Japan.
Journal: International journal of clinical oncology
Published: August 31, 2025
Bridging therapy with valemetostat to allogeneic hematopoietic cell transplantation for adult T-cell leukemia/lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: August 27, 2025
Convective rainfall drives behavioral shifts across multiple foraging scales in breeding seabirds.
Journal: Movement ecology
Published: June 25, 2025
Valemetostat Therapy for Relapsed Adult T-Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Hematological oncology
Published: April 19, 2025
Age-related differences in donor selection priorities for allogeneic hematopoietic transplantation.
Journal: Haematologica
Published: April 08, 2025
Heterogeneity of Survival Benefit Conferred By Letermovir.
Journal: Transplantation and cellular therapy
Published: March 13, 2025
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T-Cell Leukemia/Lymphoma in the Pre-Letermovir Era.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 05, 2025
Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia.
Journal: Bone marrow transplantation
Published: February 14, 2025
Last Updated: 09/26/2026